| Literature DB >> 28839253 |
Dayang Zou1, Yong Huang2, Wei Liu1, Zhan Yang1, Derong Dong1, Simo Huang1, Xiaoming He1, Da Ao1, Ningwei Liu1, Shengshu Wang1, Yong Wang1, Yigang Tong2, Jing Yuan3, Liuyu Huang4.
Abstract
Two novel New Delhi metallo-β-lactamase-1 (NDM-1)-positive plasmids containing a complete composite transposon, Tn125, from two respective Acinetobacter towneri isolates were characterized. Plasmid pNDM-GJ01 (30,293 bp) isolated from A. towneri G165 did not show homology to any known plasmid structure, except for the transposon Tn125 containing bla NDM-1. A novel repB gene and two XRE-type transcriptional regulators were found in pNDM-GJ01. Plasmid pNDM-GJ02 (62,011 bp) isolated from A. towneri G295 showed the highest homology to pBJAB0715 (41% coverage, 99% nucleotide identity). In addition to the bla NDM-1-harbouring transposon Tn125, pNDM-GJ02 also had an IS26-composite transposon, which contains ISCR1 and two class 1 integrons carrying different cassette arrays. Both clinical isolates were highly resistant to β-lactams and susceptible to tigecycline and colistin. Ten other resistance genes were detected in G295, and one other resistance gene was detected in G165. No transconjugant was obtained from any of the donors by broth and filter mating. The emergence of these two novel plasmids carrying NDM-1 in Acinetobacter spp., pNDM-GJ01 and pNDM-GJ02, suggests Tn125 mobile integration.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28839253 PMCID: PMC5571222 DOI: 10.1038/s41598-017-09624-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Antimicrobial susceptibility profiles (MICs in mg/L) of NDM-producing Acinetobacter towneri.
| Isolate | Antibiotics | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAZ | CTX | IMP | MEM | AMK | GEN | TOB | CIP | OFX | SMZ | TET | ATM | TIG | COL | |
| G165 | >256 | >256 | 16 | 16 | 64 | 8 | 8 | 32 | 32 | >256 | 2 | 4 | 0.25 | 0.5 |
| G295 | >256 | >256 | 16 | 16 | 128 | 8 | 16 | 8 | 8 | >256 | 4 | 4 | 0.25 | 0.5 |
CAZ, ceftazidime; CTX, cefotaxime; IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; TOB, tobramycin; CIP, ciprofloxacin; OFX, ofloxacin; SMZ, sulfamethoxazole; TET, tetracycline; ATM, aztreonam; TIG, tigecycline; COL, colistin.
Figure 1Circular maps of plasmids pNDM-GJ01. Starting from the outside, the first outer circle contains the coordinates of the complete plasmid circle and open reading frames (ORFs). The white arrows represent the direction of transcription. In addition, coding sequences, with known gene names reported in the NCBI database, are indicated by grey arrows. The second circle indicates the functional sequence blocks. The third circle indicates the GC content of plasmids, and the innermost circle indicates the GC-skew of the plasmids.
Figure 2Features of transposon Tn125 and its target site duplications. Arrows indicate genes and their transcription orientations, and all regions are not drawn to scale. Similar structures and high sequence homology are shown by the dotted line. The 3-bp Tn125 target sites in each plasmid are indicated by thin arrows. Un1 and Un2 indicate unknown reading frames encoding hypothetical proteins, and res indicates a gene encoding resolvase.
Figure 3Circular maps of plasmids pNDM-GJ02. The legend of Fig. 3 was same as that of Fig. 1.